Novel therapeutic strategies： targeting cancer metastasis

doi:10.3760/cma.j.cn371439-20240811-00089

Abstract

Abstract:

Tumor-related death is often associated with tumor metastasis. Metastasis process includes the acquisition of dissemination traits of tumor cells， dormancy awakening， and distant growth. Changing dissemination traits of cancer cells， maintaining and killing dormant tumor cells， editing pre-metastatic microenvironment， and reprogramming hallmarks of cancer will be key to block tumor metastasis. Bevacizumab， denosumab and cilengitide have been approved for clinical therapies. Tumor screening based on blood tests combined with artificial intelligence will provide new targeted metastasis strategies for clinical treatment.

Key words: Neoplasms, Neoplasm metastasis, Therapeutics

Zhang Baihong, Yue Hongyun. Novel therapeutic strategies： targeting cancer metastasis[J]. Journal of International Oncology, 2025, 52(8): 528-531.

References 36

[1]	Gerstberger S, Jiang Q, Ganesh K. Metastasis[J]. Cell, 2023, 186(8): 1564-1579. DOI: 10.1016/j.cell.2023.03.003.
[2]	Ganesh K, Massagué J. Targeting metastatic cancer[J]. Nat Med, 2021, 27(1): 34-44. DOI: 10.1038/s41591-020-01195-4.
[3]	Ganesh K. Uncoupling metastasis from tumorigenesis[J]. N Engl J Med, 2023, 388(7): 657-659. DOI: 10.1056/NEJMcibr2213497.
[4]	Coban B, Bergonzini C, Zweemer AJM, et al. Metastasis: crosstalk between tissue mechanics and tumour cell plasticity[J]. Br J Cancer, 2021, 124(1): 49-57. DOI: 10.1038/s41416-020-01150-7.
[5]	Pérez-González A, Bévant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy[J]. Nat Cancer, 2023, 4(8): 1063-1082. DOI: 10.1038/s43018-023-00595-y.
[6]	Boumahdi S, de Sauvage FJ. The great escape: tumour cell plasticity in resistance to targeted therapy[J]. Nat Rev Drug Discov, 2020, 19(1): 39-56. DOI: 10.1038/s41573-019-0044-1.
[7]	Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer[J]. Science, 2023, 379(6632): eaaw3835. DOI: 10.1126/science.aaw3835.
[8]	Crunkhorn S. Blocking breast cancer metastasis[J]. Nat Rev Drug Discov, 2022, 21(3): 180. DOI: 10.1038/d41573-022-00026-0.
[9]	Nair PR, Danilova L, Gómez-de-Mariscal E, et al. MLL1 regulates cytokine-driven cell migration and metastasis[J]. Sci Adv, 2024, 10(11): eadk0785. DOI: 10.1126/sciadv.adk0785.
[10]	Richbourg NR, Irakoze N, Kim H, et al. Outlook and opportunities for engineered environments of breast cancer dormancy[J]. Sci Adv, 2024, 10(10): eadl0165. DOI: 10.1126/sciadv.adl0165.
[11]	Correia AL. Locally sourced: site-specific immune barriers to metastasis[J]. Nat Rev Immunol, 2023, 23(8): 522-538. DOI: 10.1038/s41577-023-00836-2.
[12]	Xia F, Ma Y, Chen K. Genome-wide in vivo screen of circulating tumor cells identifies SLIT2 as a regulator of metastasis[J]. Sci Adv, 2022, 8(35): eabo7792. DOI: 10.1126/sciadv.abo7792.
[13]	Baek AE. Metastatic dormancy needs STING[J]. Sci Signal, 2023, 16(780): eadi1372. DOI: 10.1126/scisignal.adi1372.
[14]	Micalizzi DS, Che D, Nicholson BT, et al. Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody[J]. Proc Natl Acad Sci U S A, 2022, 119(43): e2209563119. DOI: 10.1073/pnas.2209563119.
[15]	Gkountela S, Castro-Giner F, Szczerba BM, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding[J]. Cell, 2019, 176(1/2): 98-112.e14. DOI: 10.1016/j.cell.2018.11.046.
[16]	Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer[J]. Cell, 2022, 185(8): 1356-1372.e26. DOI: 10.1016/j.cell.2022.02.027.
[17]	Zhang F, Guo Z, Li Z, et al. Biohybrid microrobots locally and actively deliver drug-loaded nanoparticles to inhibit the progression of lung metastasis[J]. Sci Adv, 2024, 10(24): eadn6157. DOI: 10.1126/sciadv.adn6157.
[18]	Yu Y, Cheng Q, Ji X, et al. Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis[J]. Sci Adv, 2022, 8(49): eadd3599. DOI: 10.1126/sciadv.add3599.
[19]	Kaczanowska S, Kaplan RN. Mapping the switch that drives the pre-metastatic niche[J]. Nat Cancer, 2020, 1(6): 577-579. DOI: 10. 1038/s43018-020-0076-9.
[20]	Sharma P, Goswami S, Raychaudhuri D, et al. Immune checkpoint therapy-current perspectives and future directions[J]. Cell, 2023, 186(8): 1652-1669. DOI: 10.1016/j.cell.2023.03.006.
[21]	Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation—have anti-inflammatory therapies come of age?[J]. Nat Rev Clin Oncol, 2021, 18(5): 261-279. DOI: 10.1038/s41571-020-00459-9.
[22]	Cao Y, Langer R, Ferrara N. Targeting angiogenesis in oncology, ophthalmology and beyond[J]. Nat Rev Drug Discov, 2023, 22(6): 476-495. DOI: 10.1038/s41573-023-00671-z.
[23]	Hofbauer LC, Bozec A, Rauner M, et al. Novel approaches to target the microenvironment of bone metastasis[J]. Nat Rev Clin Oncol, 2021, 18(8): 488-505. DOI: 10.1038/s41571-021-00499-9.
[24]	Liu F, Wu Q, Dong Z, et al. Integrins in cancer: emerging mechanisms and therapeutic opportunities[J]. Pharmacol Ther, 2023, 247: 108458. DOI: 10.1016/j.pharmthera.2023.108458.
[25]	Whiteley AE, Ma D, Wang L, et al. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis[J]. Science, 2024, 384(6702): eadh5548. DOI: 10.1126/science.adh5548.
[26]	Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance[J]. Nat Rev Cancer, 2022, 22(3): 157-173. DOI: 10.1038/s41568-021-00427-0.
[27]	Demicco M, Liu XZ, Leithner K, et al. Metabolic heterogeneity in cancer[J]. Nat Metab, 2024, 6(1): 18-38. DOI: 10.1038/s42255-023-00963-z.
[28]	Vogel FCE, Chaves-Filho AB, Schulze A. Lipids as mediators of cancer progression and metastasis[J]. Nat Cancer, 2024, 5(1): 16-29. DOI: 10.1038/s43018-023-00702-z.
[29]	Battaglia TW, Mimpen IL, Traets JJH, et al. A pan-cancer analysis of the microbiome in metastatic cancer[J]. Cell, 2024, 187(9): 2324-2335. DOI: 10.1016/j.cell.2024.03.021.
[30]	Wang Y, Narasimamurthy R, Qu M, et al. Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis[J]. Nat Cancer, 2024, 5(4): 546-556. DOI: 10.1038/s43018-024-00759-4.
[31]	Zahalka AH, Frenette PS. Nerves in cancer[J]. Nat Rev Cancer, 2020, 20(3): 143-157. DOI: 10.1038/s41568-019-0237-2.
[32]	Cambria E, Coughlin MF, Floryan MA, et al. Linking cell mechanical memory and cancer metastasis[J]. Nat Rev Cancer, 2024, 24(3): 216-228. DOI: 10.1038/s41568-023-00656-5.
[33]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. DOI: 10.3760/cma.j.cn371439-20240318-00061.
[34]	Ho D. Artificial intelligence in cancer therapy[J]. Science, 2020, 367(6481): 982-983. DOI: 10.1126/science.aaz3023.
[35]	Pan C, Schoppe O, Parra-Damas A, et al. Deep learning reveals cancer metastasis and therapeutic antibody targeting in the entire body[J]. Cell, 2019, 179(7): 1661-1676.e19. DOI: 10.1016/j.cell.2019.11.013.
[36]	Micalizzi DS, Sequist LV, Haber DA. Deploying blood-based cancer screening[J]. Science, 2024, 383(6681): 368-370. DOI: 10.1126/science.adk1213.